西柚加速器官网-西柚加速器官网入口-ios苹果版app手机版安卓PC客户端下载

In March, laboratory-based research at Harvard was put on hold, maintaining only the most critical functions to safeguard materials that are essential to our mission of finding cures and better treatments for human disease. In May, the university announced its research laboratory re-entry plan, and has been preparing for re-entry in fidelity with federal, state, local and university policy and requirements. Visit the Harvard University coronavirus website for university-wide information, and the ISSCR coronavirus page for stem-cell community resources.

西柚加速器官网-西柚加速器官网入口-ios苹果版app手机版安卓PC客户端下载

bluelight翻墙

Read more about HSCI

Research

HSCI bridges the gaps in traditional research funding to encourage bold thinking and launch scientific careers.

Through our disease programs, we channel world-class resources, both intellectual and technological, toward some of the most prevalent, devastating diseases for which stem cell research holds promise.

In addition, our seed grants and junior faculty programs provide funding for innovative, early-stage projects in stem cell research. This allows up-and-coming scientists to pursue "high risk/high reward" avenues of research that might be difficult to fund from other sources.

How does stress affect stem cells? Here, we see elaborate sympathetic innervation (magenta) around melanocyte stem cells (yellow). Acute stress has triggered the release of large amounts of norepinephrine, depleting the melanocyte stem cells and causing hair to lose color. Image courtesy of Hsu Laboratory, Harvard University
  • Blood Diseases
  • bluelight翻墙
  • Cardiovascular Diseases
  • Diabetes
  • bluelight翻墙
  • Musculoskeletal Disease
  • Nervous System Diseases
  • Skin Diseases

 

  • Fibrosis & Aging
  • Stem Cells as Tools

 

All Research Areas

bluelight下载

Protecting beta cells against type 1 diabetes

bluelight安卓版

Gut microbiome influences ALS outcomes

HSCI scientists identify gut-brain connection in ALS

西柚加速器官网-西柚加速器官网入口-ios苹果版app手机版安卓PC客户端下载

Wednesday, July 29, 2024

西柚加速器官网-西柚加速器官网入口-ios苹果版app手机版安卓PC客户端下载

Wednesday, July 29, 2024
More News

西柚加速器官网-西柚加速器官网入口-ios苹果版app手机版安卓PC客户端下载

bluelight安卓版 Sep 24

4th Biennial International Ocular Regeneration Symposium | From Bench to Bedside

blue lamp下载 to 6:00pm

西柚加速器官网-西柚加速器官网入口-ios苹果版app手机版安卓PC客户端下载

TBA

You're invited to join clinicians and basic scientists at the upcoming International Symposium on Ocular Regeneration in 2024. Lectures and panel discussions will focus on how to transform basic research into novel treatments for degenerative eye diseases of the anterior and posterior segments.

...

Read more about 4th Biennial International Ocular Regeneration Symposium | From Bench to Bedside

HSCI Faculty

Doug Melton and David Scadden, founding co-directors of the Harvard Stem Cell Institute.

HSCI has been breaking down barriers to collaboration in stem cell science since 2004. We provide fertile ground for more than 350 research faculty and their labs, across the university’s schools, centers, teaching hospitals, and partner companies, to share knowledge and pursue bold new ideas.

With Harvard as a wellspring of discovery and a strong network that embraces new ways of working, we are better equipped than ever to change human health in ways that will benefit all of society.

Executive Committee

西柚加速器官网-西柚加速器官网入口-ios苹果版app手机版安卓PC客户端下载

bluelight翻墙

From Lab to Clinic

西柚加速器官网-西柚加速器官网入口-ios苹果版app手机版安卓PC客户端下载

A key part of our mission is to move research out of the lab and into the clinic. Since our founding, we have been forging a clear path to translating discoveries into products that benefit patients. Now, we have the flexibility to organize people across institutions and sectors to tackle specific biological problems so we can make a lasting difference in people's lives.

bluelight安卓版

bluelight翻墙

Stem-cell research news delivered straight to your inbox.

Sign up for the HSCI monthly newsletter

Subscribe